Share Name Share Symbol Market Type Share ISIN Share Description
Summit Corporation LSE:SUMM London Ordinary Share GB00BN40HZ01 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 187.50p 185.00p 190.00p 190.00p 187.50p 190.00p 121 08:00:03
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 2.3 -25.7 -35.0 - 116.11

Summit Corp Share Discussion Threads

Showing 39176 to 39199 of 39200 messages
Chat Pages: 1568  1567  1566  1565  1564  1563  1562  1561  1560  1559  1558  1557  Older
DateSubjectAuthorDiscuss
16/1/2018
20:16
For those who want to find further background information on Discuva just look at their current twitter account. hTTps://twitter.com/DiscuvaLtd
chrisatrdg
15/1/2018
08:55
NASDAQ closed today for Martin Luther King day. Haven't been here since Christmas and things are looking good. Crossing fingers and toes for some (even small) significant 24 wk improvement in DMD P2 muscle biopsy. Having taken a look at activity here since New Year, it seems that simple proof of Utrophin Modulation concept may be enough encouragement for Sarepta to buy the DMD project and Summit to sail off into the sunset as a company specialising in antibiotics ... with a much enhanced share price ... "Trebles all round!" (Private Eye quote - though no irony intended)
hugus maximus
12/1/2018
16:02
$44 TP broker note also rather helps. They certainly have a number options open to them going forward. A lot will depend on DMD results.
waterloo01
12/1/2018
15:57
Think the MMs must read this board - a mark up !
luminoso
12/1/2018
15:32
Sarepta threatening 60 dollars. Seems a bouyant market for biotech at present. Good time to get some decent results out.
luminoso
12/1/2018
15:31
There certainly always seems to be a delay in marking the price up on AIM, when nasdaq is rising. Question of disbelief that it will hold maybe ?
luminoso
12/1/2018
08:34
There I was thinking just because we was up in the US at the close and a couple of percent after hours that we would be blue today, it seems we only follow US down rather than up gla
football
11/1/2018
21:16
NASDAQ closed at $12.73 & equates to £1.89 using 1.35 US$ to the £ - will be interesting to see what happens on AIM Friday.
chrisatrdg
11/1/2018
18:05
Thank you. I think i knew that but just hoped it was 4 ha
filmster
11/1/2018
17:28
Is nasdaq 5 shares of uk shares or 4? i can't remember.
filmster
11/1/2018
17:04
Looks to be making a push for $13. New uptrend?
waterloo01
10/1/2018
23:01
Edited: Wrong thread.
maxwellsdemon
10/1/2018
20:11
Well, Let me be the first to say that I invested here for the DMD and that alone ! The passion and commitment to her task of Prof Kay Davies brought me here. Plus the output of the BOD was unequivocally DMD focussed for many years, in fact until very recently ! DMD was always described as the company maker. I saw the C Diff project as a way of funding DMD through to P3 and maybe beyond. However reality set in when it was clear that Big Pharma were tired of anti-biotics and saw no real value in them, being as short sighted as me, apparently. There was going to be no early pay day to progress DMD. It was really the report by Jim O'Neill on anti-biotics which awoke me to the potential future of our C. Diff drug. Plus the inexorable rise of Sarepta in defiance of gravity (in the form of test results and efficacy). Clearly to get as far as they have with their flawed drug, they must be the favoured FDA choice for advancing DMD solutions. So, sorry Kay, but the future of your work is probably heading across the Atlantic. With their lobbyists and with senators in their pockets, they are no doubt the future of DMD. Hopefully our results will be good and attract a big cheque.
luminoso
10/1/2018
18:02
If it keeps rising states side, we could perhaps get some new interest here tomoz gla lth's
abergele
10/1/2018
17:49
Hi waterloo01 Just about to say the same & it has been a long time coming!
chrisatrdg
10/1/2018
16:57
$12 bucks again. Seems like a long time coming!
waterloo01
10/1/2018
12:04
I too have always thought that Summits C-Diff drug was the ace in the pack & remember so well when Glyn went through the phase 1 results at an AGM a few years back - he was more than enthusiastic.
chrisatrdg
10/1/2018
10:14
It's what got me invested in the first place as well. Should be an interesting few months.
waterloo01
10/1/2018
09:39
Hi Waterloo,Many thanks for the link to the Seeking Alpha review; the best summary I have seen of SMMT science and commercial prospects/valuation. Although DMD grabs the headlines I have always been chiefly invested for the C.Diff antibiotic with its broader value to society - we lost a dear friend to C.Diff many years ago.Cheers, tightfist
tightfist
09/1/2018
20:01
Sarepta Therapeutics (SRPT) Presents At 36th Annual J.P. Morgan Healthcare Conference - Slideshow: hTTps://seekingalpha.com/article/4136321-sarepta-therapeutics-srpt-presents-36th-annual-j-p-morgan-healthcare-conference-slideshow?auth_param=14cn1a:1d5a444:3a5c3db6da1276bcb23ee563635b8831&uprof=46&dr=1
chrisatrdg
09/1/2018
18:44
My basis for holding has always been the antibiotic view for C.diff.. a wider treatment of persons rather than the smaller DMD cases..imho..gla lth's
abergele
09/1/2018
15:41
Interesting as they are basing most of the value on RDZ! We have conservatively modeled the per share value of each compound and generated a 12-month price target of $44/share. Given the recent price behavior of the stock, the current share price makes a compelling case as a lower risk, high reward investment.
waterloo01
09/1/2018
14:55
Edit - didn't see someone had already posted seeking alpha story !
luminoso
09/1/2018
14:48
It is and they have no vested interest. Suntrust note last week was also very positive. Webcast this afternoon. Sit tight IMO as we get to an inflection point this quarter!
waterloo01
Chat Pages: 1568  1567  1566  1565  1564  1563  1562  1561  1560  1559  1558  1557  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V: D:20180116 23:32:27